← Human Trials & Peer-Reviewed Studies

A creatine-protein-carbohydrate supplement enhances responses to resistance training.

Plain-language guide to PMID 17986903 (2007): double-blind randomized controlled trial of Creatine.

Key Facts

PMID
17986903
Journal
Medicine and science in sports and exercise
Year
2007
Study type
Randomized Controlled Trial
Authors
Cribb PJ et al. (3 authors)
DOI
10.1249/mss.0b013e31814fb52a

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Creatine, published as a randomized controlled trial.

Studies attributing gains in strength and lean body mass (LBM) to creatine monohydrate (CrM) during resistance exercise (RE) training have not assessed these changes alongside cellular and subcellular adaptations.

Additionally, CrM-treated groups have seldom been compared with a group receiving a placebo similar in nitrogen and energy.

The purpose of this study was to examine the effects of a CrM-containing protein-carbohydrate (PRO-CHO) supplement in comparison with a supplement containing a similar amount of nitrogen and energy on body composition, muscle strength, fiber-specific hypertrophy, and contractile protein accrual during RE training.

Who Took Part

PubMed tags the participants as men only.

How the Study Was Run

In design terms this was a randomized, double-blind and placebo-controlled study.

Because people in this Creatine study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Creatine.

The comparison arm used a placebo, so changes seen with Creatine could be set against what happens without it.

What Was Measured

PubMed files the paper under topics including Body Composition, Creatine, Dietary Carbohydrates, Dietary Proteins, Dietary Supplements, Victoria and Weight Lifting.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Creatine.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2007 (Medicine and science in sports and exercise), a journal based in United States.

More context: all human trials.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.